Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

HBI 2026: Expanding into Saudi Arabia: What actually works?

Saudi Arabia’s healthcare system is evolving rapidly, creating substantial opportunities for private investors and operators. Central to this transformation is Vision 2030, the national plan to diversify the economy and shift healthcare from being predominantly publicly funded, around 70 percent, to being largely driven by the private sector.
April 9, 2026

Healthbridge buys AI scribe Nora

Healthbridge, a South African health technology company, has acquired Nora, a London-based AI medical scribe. With this acquisition, it will now embed Nora’s AI capabilities directly into its clinical platform.
April 9, 2026

HBI 2026: Age concerns; Redesigning healthcare to cope with the demands of an ageing population

Speakers on the ‘Age concerns: Redesigning healthcare to cope with the demands of an ageing population’ panel at HBI 2026 painted a rough outline of how healthcare systems need to evolve to cope with ageing populations. Broad areas of focus included: better integration between different types of care, aided by better use of data and tracking of outcomes; more holistic treatment of patients, many of whom have comorbidities, including focusing on and measuring what matters to them; and making full use of the automation capabilities provided by new tech.
April 9, 2026

Germany’s Adragos Pharma buys Sanofi sterile injectables site in France

German contract development and manufacturing organisation (CDMO) Adragos Pharma, backed by private equity firm FSN Capital and German family office Prange Group, has acquired a large sterile injectables manufacturing site from French pharmaceutical company Sanofi in Maisons-Alfort, near Paris. 
April 9, 2026

Medicum Group acquires Fertilitas, becomes Estonia’s largest private health fund partner

Medicum Group, an Estonia-based provider of general and specialised medical services backed by pan-Baltic private equity firm Livonia Partners, has acquired AS Fertilitas, a provider of otorhinolaryngology, gynaecology, and surgical care. The combined entity is set to become the largest private contractual partner of the Estonian Health Insurance Fund in specialised medical care, offering diagnostic and treatment services across 18 medical specialties.
April 9, 2026

HBI 2026: Building the future of femtech through data and AI

The HBI 2026 included a session on femtech featuring Rhiannon White, CEO of Clue; Mario Aichlseder, Founder and CEO of Hello Inside; and Samuel Levy, Founding Partner at Lauxera Capital Partners. The discussion looked at how femtech is evolving, what makes up a “femtech stack”, and where the biggest opportunities lie in consumer-driven women’s health. If you think of a stack as the different layers that create value, in this space that can include reproductive data, metabolic insights, AI, behaviour change, clinical validation, and more. The panel explored how companies and investors are approaching these layers, and which ones are actually scalable and worth investing in.
April 2, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us